Codify — Article

TRUTH in Labeling Act mandates federal front‑of‑package nutrition warnings

Requires HHS to finalize a federal front‑of‑package rule, add child‑specific reference values, and require disclosure of non‑nutritive sweeteners to drive clearer choices and product reformulation.

The Brief

This bill directs the Department of Health and Human Services to finalize a federal front‑of‑package (FOP) nutrition labeling rule and to strengthen how nutrient information reaches shoppers. It focuses on making high levels of added sugars, sodium, and saturated fat plainly visible on a product’s principal display panel and requires disclosure when non‑nutritive sweeteners are present.

The measure also targets foods for infants and toddlers by creating age‑specific reference values and aligning child guidance with the Dietary Guidelines. For professionals: the bill creates new labeling design and disclosure obligations, a compressed rulemaking deadline, and a mechanism that could push manufacturers toward reformulation — with consequential compliance and enforcement questions for industry and regulators alike.

At a Glance

What It Does

The bill requires the Secretary of Health and Human Services to finalize the proposed FDA rule titled “Food Labeling: Front‑of‑Package Nutrition Information” within 180 days and to promulgate FOP labels that call out high amounts of added sugars, sodium, and saturated fat on the principal display panel. It also mandates a factual disclosure when non‑nutritive sweeteners are present and directs HHS to set Daily Reference Values and percent Daily Values for infants and to update those for children ages 1–3, aligned with the 2020–2025 Dietary Guidelines.

Who It Affects

Packaged‑food manufacturers, especially those selling child‑oriented products and infant/toddler foods, will have new label design and disclosure obligations. The FDA/HHS will lead an expedited rulemaking, and retailers and private‑label producers will face relabeling and inventory turnover decisions. Pediatricians, nutrition educators, and public‑health advocates are directly affected by the change in how nutrient risk is communicated.

Why It Matters

This creates the first statutory push at the federal level for a uniform FOP warning system tied to age‑specific reference values, shifting from voluntary or state systems toward a nationwide standard. That standard is likely to change ingredient formulations, packaging strategies, and compliance workflows across the food sector, and it answers specific public‑health concerns about children’s exposure to non‑nutritive sweeteners.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

The bill makes the front‑of‑package proposed rule that the FDA published (90 Fed. Reg. 5426, Jan. 16, 2025) the government’s instruction to move from proposal to final rule within a short statutory window.

It requires labels on the principal display panel that specifically identify when foods are ‘‘high’’ in added sugars, sodium, or saturated fat, and it requires a separate label for each nutrient that meets the threshold. When non‑nutritive sweeteners are present, the label must include a factual statement advising that such sweeteners are not recommended for children, and that disclosure must appear adjacent to any applicable ‘‘high’’ labels.

For children’s products, the bill removes a prior regulatory exception and makes the FOP requirements applicable to foods represented as for infants through 12 months and children ages 1–3 (infant formula is carved out). To support age‑appropriate warnings, the Secretary must establish Daily Reference Values and percent Daily Values for infants and update those for ages 1–3 so they align with the 2020–2025 Dietary Guidelines.

The statute contemplates a practical sequence: if finalizing the FOP rule would be delayed by completing those reference values, HHS must issue the rule first and then amend it later to add the infant/child reference numbers.The bill is prescriptive about label placement (principal display panel) and format (a ‘‘High in’’ phrase plus an exclamation‑point icon and separate nutrient labels), which narrows how manufacturers can design warnings. It also authorizes HHS to revise existing FDA limits for the ‘‘low sodium’’ nutrient content claim to 115 milligrams per reference amount customarily consumed or per 100 grams to reflect current science.

Together, those mechanics shift decision‑making: the agency determines thresholds and templates, and industry must adapt packaging, product formulation, or marketing to comply.

The Five Things You Need to Know

1

The Secretary must finalize the FDA’s proposed FOP rule within 180 days of enactment (references: proposed rule 90 Fed. Reg. 5426).

2

FOP labels must show separate, principal‑panel warnings identifying foods that are ‘‘High in’’ added sugars, sodium, or saturated fat, using a conspicuous exclamation‑point icon.

3

If a product contains non‑nutritive sweeteners, the principal display panel must include an adjacent factual statement that such sweeteners are not recommended for children.

4

The statute requires HHS to establish Daily Reference Values and percent Daily Values for infants (up to 12 months) and to update those values for children ages 1–3 to align with the 2020–2025 Dietary Guidelines, with a contingency allowing the rule to be issued first and revised later.

5

The bill explicitly authorizes HHS to revise 21 C.F.R. §101.61(b) to set the low‑sodium nutrient content claim limit to 115 mg per reference amount customarily consumed or per 100 g, aligning the regulatory claim limit with current nutrition science.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Section 1

Short title

Identifies the act as the ‘‘Transparency, Readability, Understandability, Truth, and Helpfulness in Labeling Act’’ or the ‘‘TRUTH in Labeling Act.’

Section 2

Findings supporting the policy

Summarizes evidence and policy rationales: higher than recommended intake of added sugars, sodium, and saturated fat; research showing FOP labels change purchasing behavior; the distributional benefit for shoppers with lower nutrition literacy; and concerns that reformulation can replace sugar with non‑nutritive sweeteners unless those are also disclosed. These findings create the statutory basis for applying FOP rules to child‑targeted foods and for the non‑nutritive sweetener disclosure requirement.

Section 3(a)

Mandated finalization of the proposed FOP rule

Requires the Secretary of HHS to finalize the specific proposed rule titled ‘‘Food Labeling: Front‑of‑Package Nutrition Information’’ within 180 days. Practically, that converts an agency proposal into a statutory deadline for substantive rulemaking, compressing the timeframe for notice‑and‑comment work and signaling that the agency must prioritize the FOP standard in its rulemaking docket.

3 more sections
Section 3(b)

Label content and scope — principal display panel warnings and sweetener disclosure

Directs that covered foods bear FOP labels on the principal display panel that identify high amounts of added sugars, sodium, and saturated fat; mandates separate labels per nutrient; and requires the use of the phrase ‘‘High in’’ with an exclamation‑point icon. If applicable, the rule requires an adjacent factual statement declaring the presence of non‑nutritive sweeteners and advising they are not recommended for children. It further removes a regulatory exception so these requirements apply to foods represented for infants (through 12 months) and children ages 1–3, excluding infant formula.

Section 3(c)

Daily Reference Values for infants and children and procedural sequencing

Directs HHS to set Daily Reference Values and percent Daily Values for infants and to update those for children 1–3 consistent with the 2020–2025 Dietary Guidelines; it also provides that if establishing those numeric reference values would delay issuing the final FOP rule, HHS must publish the rule first and amend it later to add the age‑specific numbers. This sequencing reduces the chance that technical DRV development blocks the statutory deadline while ensuring the label thresholds ultimately reflect child nutrition guidance.

Section 3(d)

Regulatory alignment for sodium claims

Clarifies that nothing in the new requirements prevents HHS from revising 21 C.F.R. §101.61(b) to update the ‘‘low sodium’’ nutrient content claim threshold to 115 mg per reference amount customarily consumed or per 100 grams, aligning nutrient content claim limits with the Act’s nutritional priorities and current science.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Parents and caregivers of infants and toddlers — Clearer, front‑of‑package warnings and child‑specific reference values make it easier to identify products with high levels of nutrients of concern or with non‑nutritive sweeteners, supporting quicker, safer purchasing decisions for young children.
  • Consumers with lower nutrition literacy and time‑constrained shoppers — Prominent principal‑panel labels and simple icons shorten the information gap that the Nutrition Facts panel alone may not close, improving informed choices at the point of sale.
  • Public‑health and pediatric organizations — The statute aligns federal labeling with public‑health evidence on reducing exposure to added sugars and sodium and explicitly addresses children’s exposure to non‑nutritive sweeteners, which many such organizations have urged.

Who Bears the Cost

  • Packaged‑food manufacturers and brand owners — They must redesign primary packaging, update artwork, possibly reformulate products to avoid ‘‘high in’’ thresholds, and manage inventory transitions and compliance testing.
  • Small producers and importers — Smaller firms face disproportionate per‑unit relabeling costs and administrative burdens to implement new principal‑panel warnings and to verify ingredient and sweetener declarations.
  • HHS/FDA — The agency assumes a compressed, legally mandated timeline for finalizing a significant rule, then must develop infant/child DRVs and potentially defend revisions to existing nutrient content claims, requiring internal resources and enforcement planning.

Key Issues

The Core Tension

The central tension is between delivering blunt, easy‑to‑use warnings that materially improve consumer decisions—especially for parents and low‑literacy shoppers—and imposing a rigid, one‑size‑fits‑all regulatory design that may misclassify nuance in pediatric nutrition, drive unintended reformulation strategies, and impose heavy, front‑loaded compliance costs on manufacturers and regulators.

The bill creates implementation dilemmas that are not purely technical. First, setting numeric thresholds that trigger a ‘‘High in’’ warning for infants and toddlers requires normative choices about appropriate Daily Reference Values for very young children—population groups for whom intake recommendations are narrower and evidence in packaged foods is less standardized.

Translating the Dietary Guidelines into percent Daily Values for infants will require methodological decisions about serving sizes, reference amounts customarily consumed, and whether to apply the same percent thresholds used for adults.

Second, the bill’s labeling mandates risk predictable industry responses that are hard to classify as strictly positive or negative. The disclosure of non‑nutritive sweeteners reduces one pathway for substitution, but manufacturers may respond by changing formulations in other ways (smaller serving sizes, use of novel additives, or marketing shifts to avoid covered claims).

Enforcement and measurement will be challenging: inspectors and compliance officers will need clear testable standards for ‘‘contains non‑nutritive sweeteners’’ and for when a product meets the ‘‘High in’’ threshold across diverse product categories. The 180‑day statutory deadline compresses the agency’s normal rulemaking timeframe, raising practical questions about whether HHS will use the contingency to issue a more skeletal rule first and fill in numeric DRVs later — a sequence that could create a period of regulatory uncertainty for industry and retailers.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.